<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15</volume><submitter>Gu J</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><pubmed_abstract>Parkinson's disease (PD) and dementia with Lewy body (DLB) are the most common synucleinopathies. &lt;i>SNCA&lt;/i> gene is a major genetic risk factor for these diseases group, and dysregulation of its expression has been implicated in the genetic etiologies of several synucleinopathies. DNA methylation at CpG island (CGI) within &lt;i>SNCA&lt;/i> intron 1 has been suggested as a regulatory mechanism of &lt;i>SNCA&lt;/i> expression, and changes in methylation levels at this region were associated with PD and DLB. However, the role of DNA methylation in the regulation of &lt;i>SNCA&lt;/i> expression in a cell-type specific manner and its contribution to the pathogenesis of PD and DLB remain poorly understood, and the data are conflicting. Here, we employed a bisulfite pyrosequencing technique to profile the DNA m</pubmed_abstract><journal>Frontiers in neuroscience</journal><pagination>652226</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8113398</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Cell-Type Specific Changes in DNA Methylation of &lt;i>SNCA&lt;/i> Intron 1 in Synucleinopathy Brains.</pubmed_title><pmcid>PMC8113398</pmcid><pubmed_authors>Kantor B</pubmed_authors><pubmed_authors>Chiba-Falek O</pubmed_authors><pubmed_authors>Murphy SK</pubmed_authors><pubmed_authors>Barrera J</pubmed_authors><pubmed_authors>Yun Y</pubmed_authors><pubmed_authors>Gu J</pubmed_authors><pubmed_authors>Beach TG</pubmed_authors><pubmed_authors>Woltjer RL</pubmed_authors><pubmed_authors>Serrano GE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cell-Type Specific Changes in DNA Methylation of &lt;i>SNCA&lt;/i> Intron 1 in Synucleinopathy Brains.</name><description>Parkinson's disease (PD) and dementia with Lewy body (DLB) are the most common synucleinopathies. &lt;i>SNCA&lt;/i> gene is a major genetic risk factor for these diseases group, and dysregulation of its expression has been implicated in the genetic etiologies of several synucleinopathies. DNA methylation at CpG island (CGI) within &lt;i>SNCA&lt;/i> intron 1 has been suggested as a regulatory mechanism of &lt;i>SNCA&lt;/i> expression, and changes in methylation levels at this region were associated with PD and DLB. However, the role of DNA methylation in the regulation of &lt;i>SNCA&lt;/i> expression in a cell-type specific manner and its contribution to the pathogenesis of PD and DLB remain poorly understood, and the data are conflicting. Here, we employed a bisulfite pyrosequencing technique to profile the DNA m</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-19T16:17:28.335Z</modification><creation>2025-04-19T16:17:28.335Z</creation></dates><accession>S-EPMC8113398</accession><cross_references><pubmed>33994928</pubmed><doi>10.3389/fnins.2021.652226</doi></cross_references></HashMap>